Kaohsiung, Taiwan

Hsi-An Chen

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Kaohsiung Medical University. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hsi-An Chen. Retrieved from https://idiyas.com/inventor/hsi-an-chen-77422y1h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hsi-An Chen: Innovator in Tetracycline Resistance

Introduction

Hsi-An Chen is a notable inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of medical research, particularly in the area of antibiotic resistance. His innovative approach combines traditional compounds with modern medical practices to address pressing health issues.

Latest Patents

Hsi-An Chen holds a patent for a method aimed at improving tetracycline resistance. This method involves providing a ginger compound combined with tetracycline to combat infections. The ginger compound includes components such as [6]-dehydrogingerdione, [6]-shogaol, and [6]-gingerol or [10]-gingerol, [6]-shogaol, and [6]-gingerol. This patent highlights his commitment to finding alternative solutions to antibiotic resistance.

Career Highlights

Hsi-An Chen is affiliated with Kaohsiung Medical University, where he conducts research and develops innovative solutions in the medical field. His work has garnered attention for its potential impact on treating infections that are resistant to conventional antibiotics.

Collaborations

Hsi-An Chen collaborates with esteemed colleagues, including Yen-Hsu Chen and Hui-Min David Wang. These partnerships enhance the research efforts and contribute to the advancement of medical science.

Conclusion

Hsi-An Chen's work exemplifies the intersection of traditional medicine and modern science. His innovative methods in addressing tetracycline resistance are paving the way for new treatments and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…